Mar 4, 2026 05:46PM
Dec 11, 2025 04:05PM
Nov 4, 2025 08:00AM
Nov 4, 2025 08:00AM
Oct 25, 2025 09:59AM
Oct 25, 2025 09:59AM
Oct 23, 2025 08:00AM Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at the American College of Gastroenterology (ACG) 2025 Annual Scientific Meeting
Aug 7, 2025 06:59AM
Jun 16, 2025 08:01AM
Jun 16, 2025 08:00AM
Jun 9, 2025 06:40AM
Jun 9, 2025 05:15AM
Jun 6, 2025 01:46PM
Jun 6, 2025 12:48PM Stifel Reiterates Buy Rating on Phathom (PHAT), PT $28, 'We leave our model unchanged, as our view reflected full 10-year exclusivity'
Jun 6, 2025 12:28PM
Jun 6, 2025 12:27PM
Jun 6, 2025 11:51AM
May 1, 2025 07:00AM
Apr 28, 2025 07:59AM
Apr 1, 2025 08:01AM
Apr 1, 2025 08:00AM Phathom Pharmaceuticals Announces Leadership Succession
Mar 31, 2025 08:00AM
Mar 31, 2025 07:59AM
Mar 6, 2025 08:00AM
Feb 15, 2025 10:00PM
Feb 7, 2025 01:34PM
Dec 12, 2024 06:44AM
Dec 11, 2024 09:38AM Stifel Comments on Phathom Pharmaceuticals Inc. (PHAT)
Dec 11, 2024 08:00AM
Nov 7, 2024 01:51PM
Nov 7, 2024 08:00AM
Oct 27, 2024 12:00PM
Aug 8, 2024 08:00AM
Jul 30, 2024 08:02AM
Jul 30, 2024 08:00AM Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Added to CVS Caremark Formularies for Commercially Insured Patients
Jul 19, 2024 10:02AM
Jul 18, 2024 08:01AM
Jul 18, 2024 08:00AM
May 15, 2024 08:00AM
May 9, 2024 08:00AM
Mar 26, 2024 08:00AM
Mar 7, 2024 08:00AM Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Feb 13, 2024 08:00AM
Feb 13, 2024 08:00AM
Dec 14, 2023 08:00AM
Dec 6, 2023 08:00AM
Dec 6, 2023 08:00AM
Nov 28, 2023 08:05AM
Nov 28, 2023 08:00AM Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn
Nov 9, 2023 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All